Allstate Corp Akero Therapeutics, Inc. Transaction History

Allstate Corp

  • $4.24 Billion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$18.65 - $25.46 $156,361 - $213,456
-8,384 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$24.81 - $32.35 $2,406 - $3,137
97 Added 1.17%
8,384 $208,000
Q1 2021

May 14, 2021
BUY
$24.04 - $34.19 $199,219 - $283,332
8,287 New
8,287 $240,000

About Akero Therapeutics, Inc.

AKRO Quotes by TradingView
  • Ticker AKRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,417,600
  • Market Cap $2.52B
  • Description
  • Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...
More about AKRO
Track This Portfolio

Track Allstate Corp Portfolio

Follow Allstate Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

News

Stay updated on Allstate Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email